(19)

(11)

EP 4 824 814 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24828962.1 (22) Date of filing: 09.12.2024

(51) International Patent Classification (IPC):  G16H 20/30(2018.01) G16H 30/40(2018.01) A61N 1/36(2006.01) G16H 20/40(2018.01) G16H 50/70(2018.01) A61N 1/372(2006.01) (52) Cooperative Patent Classification (CPC): G16H 20/40; G16H 30/40; G16H 50/70; G16H 20/30; A61N 1/37247; A61N 1/3605; A61N 1/0534; A61N 1/36139; A61N 1/36135; A61N 1/36132 (86) International application number: PCT/US2024/059150 (87) International publication number: WO 2025/128467 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 14.12.2023 US 202363610299 P (71) Applicant: Boston Scientific Neuromodulation Corporation Valencia, CA 91355 (US)	(72) Inventors: BOKIL, Hemant Cambridge, MA 02138 (US) MALEKMOHAMMADI, Mahsa Sherman Oaks, CA 91411 (US) STEINKE, G., Karl Valencia, CA 91355 (US) (74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB  Siebertstraße 3 81675 München 81675 München (DE)